MWM
TMO icon

Minot Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Minot Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$6.45M Buy
11,864
+1
+0% +$550 1.66% 15
2022
Q1 		$7.01M Buy
11,863
+62
+0.5% +$35.6K 1.51% 18
2021
Q4 		$7.87M Buy
11,801
+59
+0.5% +$36.8K 1.52% 17
2021
Q3 		$6.71M Buy
11,742
+228
+2% +$125K 1.45% 17
2021
Q2 		$5.92M Buy
11,514
+225
+2% +$106K 1.29% 24
2021
Q1 		$5.15M Buy
11,289
+780
+7% +$372K 1.32% 23
2020
Q4 		$4.89M Buy
10,509
+1,339
+15% +$628K 1.46% 20
2020
Q3 		$4.05M Buy
9,170
+392
+4% +$162K 1.53% 18
2020
Q2 		$3.18M Buy
8,778
+1,681
+24% +$563K 1.59% 20
2020
Q1 		$2.01M Sell
7,097
-43
-0.6% -$13.6K 1.44% 23
2019
Q4 		$2.43M Buy
+7,140
New +$2.16M 1.11% 28

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minot Wealth Management's TMO Position: Q2 2022 in Review

Minot Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.01% in Q2 2022, buying an estimated $550 and bringing the position to 11,864 shares worth $6.45M. The position accounts for 1.66% of the portfolio, ranked #15.

Minot Wealth Management first reported a position in TMO in Q4 2019 and has held it in 11 quarters since. The position peaked at $7.87M in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Minot Wealth Management held 11,864 shares of Thermo Fisher Scientific worth $6.45M as of Q2 2022.
  • Minot Wealth Management bought 1 Thermo Fisher Scientific share in Q2 2022, an estimated $550.
  • Thermo Fisher Scientific made up 1.66% of Minot Wealth Management's portfolio in Q2 2022, its #15 holding.
  • Minot Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 11 quarters since.
  • Minot Wealth Management's Thermo Fisher Scientific position peaked at $7.87M in Q4 2021.
  • 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.